Showing results (1061-1070 of 1,155) with videos related to

Sort By:
Pageof 116
Current Oncology (Toronto, Ont.)|August 27, 2025
Bone Health and Endocrine Therapy with Ovarian Function Suppression in Premenopausal Early Breast Cancer: A Real-Life Monocenter Experience with DenosumabAngelachiara Rotondi, Valentina Frescura, Giorgia Arcuri, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|January 4, 2021
Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New MechanismsMuhammad Ali Haidar, Hussam Jourdi, Zeinab Haj Hassan, et al.
Journal of Personalized Medicine|March 27, 2026
Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 InhibitorsIlaria Poli, Gaia Rachele Oliva, Ginevra Mongelli, et al.
Frontiers in Neurology|August 23, 2018
Multi-Center Pre-clinical Consortia to Enhance Translation of Therapies and Biomarkers for Traumatic Brain Injury: Operation Brain Trauma Therapy and BeyondPatrick M Kochanek, C Edward Dixon, Stefania Mondello, et al.
The Lancet. Neurology|August 13, 2022
Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort studyIsabel R A Retel Helmrich, Endre Czeiter, Krisztina Amrein, et al.
Ebiomedicine|May 29, 2020
Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI studyEndre Czeiter, Krisztina Amrein, Benjamin Y Gravesteijn, et al.
Cancer Research Communications|February 29, 2024
Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical ModelsAxel Sahovaler, Michael S Valic, Jason L Townson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2022
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort StudyGrzegorz S Nowakowski, Dok Hyun Yoon, Anthea Peters, et al.
The Journal of Trauma and Acute Care Surgery|June 8, 2012
Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical interventionLinda Papa, Lawrence M Lewis, Salvatore Silvestri, et al.
Expert Review of Molecular Diagnostics|November 16, 2021
Blood-based traumatic brain injury biomarkers - Clinical utilities and regulatory pathways in the United States, Europe and CanadaKevin K Wang, Jennifer C Munoz Pareja, Stefania Mondello, et al.
Pageof 116